Thuja Capital Management Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 3
- Investments
- 54
- Portfolio
- 11
- Exits
- 29
Thuja Capital Management General Information
Description
Founded in 2006, Thuja Capital Management is a venture capital firm based in Utrecht, Netherlands. The firm seeks to invest in the medical devices, diagnostics, therapeutics, medical food and food supplements sectors.
Contact Information
Website
www.thujacapital.com
Year Founded
2006
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- LSI Buidling
- Yalelaan 62
- 3584 CM Utrecht
- Netherlands
+31 06 00000000
Thuja Capital Management Investments (54)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Alveron Pharma | 08-Oct-2021 | Seed Round | 00.000 | Drug Discovery | Generating Revenue | 000000 0000000 00.0 |
| 000000000 | 30-Sep-2021 | 0000 00000 | 00.000 | Biotechnology | Startup | 000000 0000000 00.0 |
| 000000 00000000000 | 22-Sep-2020 | 00000 00000 | 000.00 | Therapeutic Devices | Generating Revenue | 000000 0000000 00.0 |
| 0000000000 | 03-Sep-2020 | 00000 00000 | 00.000 | Food Products | Clinical Trials - General | 000000 0000000 00.0 |
| 000000 | 27-Jul-2020 | 00000 00000 | 0000 | Monitoring Equipment | Generating Revenue | 0000000 000 000000000 00.0 |
| 000000 0000000 | 12-Jun-2020 | 00000 00000 | 00.000 | Surgical Devices | Generating Revenue | 000000 0000000 00.0 |
| 0000000 000000 | 16-May-2019 | 00000 00000 | 00.000 | Drug Discovery | Generating Revenue | 000000 0000000 00.0 |
| 000000 00000000000 | 23-Apr-2019 | 0000 00000 | Drug Discovery | Generating Revenue | 0000000 000 000000000 00.0 | |
| Synerkine Pharma | 25-Mar-2019 | Later Stage VC | 00.000 | Biotechnology | Pre-Clinical Trials | 000000 0000000 00.0 |
| Salvia BioElectronics | 31-Jan-2019 | Seed Round | 00.000 | Therapeutic Devices | Generating Revenue | 0000000 000000 00.0 |
Thuja Capital Management Exits (29)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| EnCare Biotech | 10-Jan-2022 | Out of Business | |
| 000000 | 02-Aug-2021 | 0000000000 | |
| 000000 | 01-Nov-2018 | 000000000000000000 | |
| 000000000 | 01-Sep-2018 | 000 00 00000000 | |
| 000000000000 | 08-May-2018 | 000000000000000000 | |
| 0000000000 | 20-Apr-2017 | 0000000000: 000000 | |
| 00000000 | 15-Mar-2017 | 000 | 00000 |
| 000000 | 10-Jul-2014 | 000 | 000.00 |
| Aratana Therapeutics | 03-Mar-2014 | Secondary Transaction - Stock Distribution | 000.00 |
| Okapi Sciences | 06-Jan-2014 | Merger/Acquisition | 000.00 |
Thuja Capital Management Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialThuja Capital Management Team (11)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Martin Solleveld | Financial Controller | Utrecht, Netherlands | |||
| Florian Ludwig Ph.D | Investment Manager | 0 | 0 | 0 | Utrecht, Netherlands |
| Daan Crommelin Ph.D | Advisory Board Member | 0 | Utrecht, Netherlands | ||
| Kathleen Marshall | Advisory Board Member | Utrecht, Netherlands | |||
| Harrold van Barlingen Ph.D | Founder & Managing Partner | 00 | 0 | 0 | Utrecht, Netherlands |
Thuja Capital Management Co-Investors (40)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Brabantse Ontwikkelings Maatschappij | 4 | 0 |
|
|
|
| Oost NL | 0 | 0 |
|
|
|
| DSM Venturing | 0 | 0 |
|
|
|
| Ackermans & van Haaren | 0 | 0 |
|
|
|
| BioGeneration Ventures | 0 | 0 |
|
|